Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
39.93
+0.81 (2.07%)
Nov 19, 2025, 2:31 PM EST - Market open
Sionna Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts that cover Sionna Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $38.83, which forecasts a -2.75% decrease in the stock price over the next year. The lowest target is $22 and the highest is $50.
Price Target: $38.83 (-2.75%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Sionna Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 3 | 4 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 4 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +25.22% | Nov 19, 2025 |
| Freedom Capital Markets | Freedom Capital Markets | Strong Buy Initiates $38 | Strong Buy | Initiates | $38 | -4.83% | Oct 17, 2025 |
| Jones Trading | Jones Trading | Strong Buy Initiates $46 | Strong Buy | Initiates | $46 | +15.20% | Sep 8, 2025 |
| Raymond James | Raymond James | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +12.70% | Sep 3, 2025 |
| RBC Capital | RBC Capital | Hold Initiates $22 | Hold | Initiates | $22 | -44.90% | Sep 3, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.05
from -15.99
EPS Next Year
-2.26
from -2.05
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | |||
| Avg | n/a | n/a | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.90 | -1.67 | |||
| Avg | -2.05 | -2.26 | |||
| Low | -2.27 | -3.04 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.